CN Patent
CN115025056A — 一种含有替加氟、吉莫斯特和奥替拉西钾的口腔崩解制剂
Assigned to First Affiliated Hospital of Zhengzhou University · Expires 2022-09-09 · 4y expired
What this patent protects
本发明涉及一种含有替加氟、吉莫斯特和奥替拉西钾的口腔崩解制剂,属于药物制剂技术领域。该片剂由替加氟、吉莫斯特、奥替拉西钾、稳定剂、填充剂、崩解剂、润滑剂、矫味剂制备而成,所述口腔崩解剂型由湿法制粒压片而成。本发明制备的口腔崩解制剂的崩解时限短、溶出度高、无砂砾感,符合口腔崩解制剂的质量标准要求,适用于工业放大化生产。
USPTO Abstract
本发明涉及一种含有替加氟、吉莫斯特和奥替拉西钾的口腔崩解制剂,属于药物制剂技术领域。该片剂由替加氟、吉莫斯特、奥替拉西钾、稳定剂、填充剂、崩解剂、润滑剂、矫味剂制备而成,所述口腔崩解剂型由湿法制粒压片而成。本发明制备的口腔崩解制剂的崩解时限短、溶出度高、无砂砾感,符合口腔崩解制剂的质量标准要求,适用于工业放大化生产。
Drugs covered by this patent
- Rilutek (RILUZOLE) · Covis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.